News

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Press Releases
Proposed Prescription Drug User Fee Act VII…
Biotechnology Innovation Organization (BIO) Chief Scientific Officer, E. Cartier Esham issued the following statement on the release of the Prescription Drug User Fee Act (PDUFA) VII performance goals letter: “The Prescription Drug User Fee…
Biden Drug Plan Adds Barriers to Seniors…
President Joe Biden today announced a slew of drug pricing reforms, including changes that would radically alter the widely successful Medicare program for seniors and people with disabilities. Rich Masters, BIO’s Chief Public Affairs and Advocacy…
BIO Announces 2021 Start-up Stadium Winner:…
Annual competition takes place during BIO’s International Convention
Letters, Testimony, & Comments
Agriculture Biotech Alliance Letter to House Ag…
On behalf of our nation’s food and agricultural stakeholder community, we write to extend our appreciation for holding today’s hearing on “Agricultural Biotechnology: 21st Century Advancements and Applications.” Biotechnology is an increasingly…
BIO Submits Statement to House Ag Joint Hearing…
The Biotechnology Innovation Organization (BIO) is pleased to submit a statement for the record to the United States House of Representatives Committee on Agriculture joint hybrid subcommittee hearing, Agricultural Biotechnology: 21st Century…
BIO Joins Letter Supporting Elaine Trevino as…
BIO is pleased to join the undersigned food and agriculture organizations and companies in supporting the nomination of Elaine Trevino to serve as Chief Agricultural Negotiator at the Office of the U.S. Trade Representative.
Amicus Briefs
BIO Files Amicus Brief in Petition for a Writ of…
BIO and AUTM have filed an amicus brief in petition for a writ of certiorari the in American Axle & Manufacturing, Inc., v. Neapco Holdings LLC, et al., at the Supreme Court of the United States. BIO and AUTM are concerned that…
BIO Files Amicus Brief in Support of Rehearing…
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology. 
BIO Files Amicus Brief on Case Addressing the…
BIO files an Amicus Brief on rehearing by the Precedential Opinion Panel of the Patent Trial and Appeal Board.
Blog Posts
GMOS and Gene Editing—Nothing to Be Afraid Of
October 21, 2021
This Halloween season, ghosts and ghouls are something to worry about! Genetic engineering? Not so much. Similar to scary campfire stories, every once in a while, someone will share a terrifying tale about how genetic…
Child Patient
October 18, 2021
By Danielle Davis, MSW  Inclusion is one of Gilead’s core values, and it not only guides how our employees work together, but also supports our commitment to eliminating health and healthcare disparities. Integrating…
Escaping the Food Allergy Prison
October 12, 2021
Every three minutes in the United States, an allergic reaction to foods sends someone to the emergency room. Today, we explore what life is like when you must avoid certain foods. But we also learn that there is hope…